CoreRx
Manufacturing · Florida, United States · 228 Employees
View Company Info for Free
About
Headquarters
14205 Myerlake Cir, Clearwater, Florida, 33760,...Phone Number
(727) 259-6950Website
www.corerxpharma.comRevenue
$31.4 MillionIndustry
Most Recent Scoops
Highlights
$14M
Total Funding Amount
<$5M
Most Recent Funding Amount
3
Number of Funding Rounds
Who is CoreRx
CoreRx is a Contract Development Manufacturing Organization (CDMO) with capabilities to support clinical and commercial manufacturing needs. Our st ate-of-the art facilities support customers' supply chain needs, and our integrated offerings provide comprehensive services for the development, manufacturing, and testing of solid, liquid and semi-solid dosage forms. Keep on top of new developments at CoreRx and throughout the drug development industry by following www.linkedin.com/company/corerx-inc-.Read more
Popular SearchesCorerx IncCoreRxCoreRx PharmaCorerxcaresCore Rx Pharmaceuticals IncSIC Code 28,283NAICS Code 32,325Show moreCoreRx Org Chart
Is CoreRx your ideal customer?
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once CoreRx has new funding data
Earning: See what the market has to say on CoreRx recently announced quarterly report
Check out if CoreRx is spiking on competitors!
Click to see if CoreRx had a recent Job posting/layoffs
CoreRx, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when CoreRx launches new products
Check if CoreRx has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at CoreRx
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Similar Companies to CoreRx
Analyze insights from companies similar to CoreRx and make strategic comparisons based on performance, financial data, growth and unique benchmarks.
- Metrics Contract Services100$47.5M
- UPM Pharmaceuticals277$41.1M
- DPT Laboratories607$204.9M
- Tapemark131$25.1M
- Tergus Pharma123$12.7M
- Mikart183$42.8M
- The Ritedose293$56.8M
- Cytovance Biologics264$26.9M
More similar companies
CoreRx financials insights
Gather financial insights about CoreRx, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
CoreRx Employee Growth Rate
Percentage of growth
1st year Mask
2nd year Mask
CoreRx Tech Stack
A closer look at the technologies used by CoreRx
Top Companies in United States
Top 10 companies in United States by revenue
Top 10 companies in United States by number of employees
Top 10 companies in United States by total funding amount
Most Recent Scoops
CoreRx News & Media
CoreRx, Inc. Completes Acquisition of Societal CDMO, Inc.
CLEARWATER, Fla.--(BUSINESS WIRE)--CoreRx, Inc. Completes Acquisition of Societal CDMO, Inc.Societal CDMO Enters Into Definitive Agreement to be Acquired by CoreRx, Inc.
Societal CDMO to be Acquired by CoreRx, Inc. to Create an Enhanced CDMO with Broad Capabilities Spanning Early-Stage Formulation Development through Commercial Manufacturing and Packaging CoreRx to Commence a Tender Offer for all Outstanding Shares of Societal CDMO, Inc. CLEARWATER, Fla. and GAINESVILLE, Ga., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO”) (Nasdaq: SCTL), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulationNovaQuest Private Equity Announces Investment In Bend Bioscience to Broaden CoreRx Offering
Bend Bioscience, based in Bend, Oregon, to focus on new innovation, product development, and manufacturing. BEND, Ore., Oct. 11, 2022 /PRNewswire/ -- Bend Bioscience and QHP Capital ("QHP"), the management company for NovaQuest Private Equity ("NQPE"), have announced plans to invest in a...CoreRx Announces Sitakant Chaudhury As Chief Financial Officer - BioProcess Online
Mr. Chaudhury, a Global Finance Executive and Leader, brings to CoreRx over 25 years of experience building, scaling, transforming and leading world-class organizations. Most recently he worked as Chief Financial Officer of Tennessee-based Aphena Pharma Solutions.
Frequently Asked Questions Regarding CoreRx
CoreRx is a Contract Development Manufacturing Organization (CDMO) with capabilities to support clinical and commercial manufacturing needs. Our state-of-the art facilities support customers' supply chain needs, and our integrated offerings provide comprehensive services for the development, manufacturing, and testing of solid, liquid and semi-soli... Read More